Target intelligence / Profile preview

Idiotype of the parent monoclonal antibody Ab1 (Ab1 idiotype)

Target
Ab1 idiotype
Molecular classification
Immunoglobulin, Antibody, Idiotype, Other
01

Overview

The idiotype of the parent monoclonal antibody Ab1 refers to the unique set of antigenic determinants, or idiotopes, located within the variable region of an antibody (Ab1) that specifically recognizes a tumor-associated antigen (TAA) (Frontiers in Immunology, 2012). This target is a central element of Jerne's idiotypic network theory, which describes the immune system as a self-regulating web of interacting antibodies (NIH, 2025). In cancer immunotherapy, the Ab1 idiotype serves as the target for anti-idiotypic antibodies (Ab2), which are designed to mimic the structural conformation of the original TAA, acting as 'internal image' antigens (Creative Biolabs). When administered as a vaccine, the Ab2 antibody induces the production of anti-anti-idiotypic antibodies (Ab3) and T-cell responses that cross-react with the tumor cells, effectively bypassing immune tolerance to self-antigens (NIH, 1986). This approach has been utilized in the development of several cancer vaccines, such as Racotumomab and Abagovomab, to stimulate a targeted anti-tumor immune response (ResearchGate, 2019). Therapeutic challenges include the potential for a human anti-mouse antibody (HAMA) response and the need to ensure that the induced immune response specifically targets the tumor without causing significant autoimmunity (NIH, 1992).

Other names
Ab1 variable regionAb1 paratopeIdiotypic determinantIdiotopeAb1 Id
02

Mechanism of action

Induction of an active immune response (Ab3) through the idiotypic network by mimicking a tumor-associated antigen.

03

Biological functions

Immune responseAntigen mimicryImmune regulationIdiotypic network
04

Disease associations

Cancer
05

Safety considerations

Human anti-mouse antibody (HAMA) responseSystemic inflammatory responseAutoimmunity
06

Interacting drugs

Racotumomab

6 more in the full profile.

07

Biomarkers

Ab3 antibody titerT-cell proliferationDelayed-type hypersensitivity (DTH)

Beyond the preview

Go deeper on Idiotype of the parent monoclonal antibody Ab1 (Ab1 idiotype).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Idiotype of the parent monoclonal antibody Ab1 (Ab1 idiotype).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call